Seeger Weiss LLP
is recognized as one of the nation's preeminent law firms handling complex individual, mass and class action litigation on behalf of consumers, investors, and injured persons nationwide. With offices in New York City's Financial District, Newark, NJ, Philadelphia, PA, and Tulsa, OK, the firm has successfully represented plaintiffs in individual, group, and class actions in a variety of practice areas, including pharmaceutical injury, securities and investment fraud, consumer protection, environmental and toxic exposures, False Claims Act, personal injury and medical malpractice, product defect, antitrust and commercial disputes. Backed by its experienced trial attorneys and proven results, Seeger Weiss LLP has the skills and resources necessary to prosecute the most complex litigation matters.
featured lawsuits
Seeger Weiss and the Zyprexa PSC Achieve a $700 Million Settlement
Eli Lilly and Christopher Seeger on behalf of the Plaintiffs' Steering Committee in the federal Zyprexa MDL, agreed to a $700 million settlement of approximately 8,000 cases against El Lilly for allegations that Zyprexa caused them to develop diabetes and diabetes-related injuries.
read more >>
Seeger Weiss LLP Investigates Asbestos-Related Injury Claims
Seeger Weiss LLP announces that it is pursuing claims of persons who have been affected by asbestos inhalation, which may lead to Pneumoconiosis or Mesothelioma. Many who have been affected by these conditions have worked in coal mines, or manufacturing plants. More information to follow.
read more >>
See All Cases >>
in the news
Seeger Weiss LLP Reports Successful Enrollment of 93 Percent of Eligible Plaintiffs in VIOXX Settlement Program
Seeger Weiss' founding partner Stephen Weiss was interviewed by a Bloomberg news staff writer to asses the current state of the Auction-Rate security class actions, pending in various courts.
Seeger Weiss LLP Announces $4.85 Billion Global Resolution of Vioxx-Related Heart Attack and Stroke Claims Against Merck & Co.
Seeger Weiss LLP announces Auction Rate Securities Lawsuit
Alabama Man Awarded $2.62 Million Verdict In First Accutane Trial Concerning Inflammatory Bowel Disease
Seeger Weiss Obtains $47.5 Million Jury Award Against Merck & Co.
News Archive >>
new lawsuits
Vioxx Third Party Payor Litigation
Auction Rate Securities Lawsuits
Ortho Evra
Fosamax
Elidel and Protopic
Accutane
home
firm profile
attorneys
practice areas
cases
newsroom
contact us
Toll Free (877) 539-4125
Full Disclaimer
Please do not communicate any confidential information before you become our client following your countersignature to a retainer agreement provided by us. Any information you do provide before the creation of an attorney-client relationship in this way will not be treated as confidential. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising
One William Street
New York, NY 10004
(212) 584-0700
550 Broad Street
Newark, NJ 07102
(973) 639-9100
1515 Market Street, Suite 1380
Philadelphia, PA 19102
(215) 564-2300
© 2008 Seeger Weiss LLP
home
firm profile
attorneys
practice areas
cases
newsroom
contact us